Status:
TERMINATED
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
Lead Sponsor:
AstraZeneca
Conditions:
Hypercholesterolaemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to compare the effectiveness and safety of rosuvastatin 5mg in lowering blood cholesterol, compared to one other medicine, atorvastatin 10mg in Asian patients in the UK.
Eligibility Criteria
Inclusion
- Self described Asian, first or second generation
- Male or female \> or = 18 years with primary hypercholesterolaemia.
Exclusion
- Use of cholesterol lowering drugs from visit 1
- Homozygous familial hypercholesterolaemia
- Active arterial disease within 3 months of study entry
- Poorly controlled diabetes
- Uncontrolled hypothyroidism
- Active liver disease
- History of alcoh/drug abuse.
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00427960
Start Date
December 1 2006
End Date
February 1 2008
Last Update
December 16 2010
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Allerton, United Kingdom
2
Research Site
Birmingham, United Kingdom
3
Research Site
Blackburn, United Kingdom
4
Research Site
Bolton, United Kingdom